Compound ID | 319
Research Programme-2-(Thiazol-2ylthio)-1β-Methylcarbapenem: SM-232721
Class: Beta-lactam (carbapenem)
| Spectrum of activity: | Gram-negative |
| Details of activity: | Cell wall inhibitor; Good activity against drug resistant infections including MRS and VRE |
| Institute where first reported: | Roche, Switzerland; Sumitomo Pharmaceuticals (Dainippon Sumitomo Pharmaceuticals, Japan) |
| Year first mentioned: | 2001 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/substance/273348421 |
| Citation: | https://journals.asm.org/doi/10.1128/aac.47.8.2471-2480.2003 |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.